These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9711782)

  • 41. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
    Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
    Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children.
    McFarland EJ; Harding PA; MaWhinney S; Schooley RT; Kuritzkes DR
    J Immunol; 1998 Jul; 161(1):513-9. PubMed ID: 9647263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection.
    Addo MM; Yu XG; Rosenberg ES; Walker BD; Altfeld M
    DNA Cell Biol; 2002 Sep; 21(9):671-8. PubMed ID: 12396610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual.
    Curiel TJ; Wong JT; Gorczyca PF; Schooley RT; Walker BD
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):61-8. PubMed ID: 7678973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of cytotoxic T-cells in HIV infection.
    Rowland-Jones S; Dong T; Krausa P; Sutton J; Newell H; Ariyoshi K; Gotch F; Sabally S; Corrah T; Kimani J; MacDonald K; Plummer F; Ndinya-Achola J; Whittle H; McMichael A
    Dev Biol Stand; 1998; 92():209-14. PubMed ID: 9554277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities.
    Buseyne F; Janvier G; Fleury B; Schmidt D; Rivière Y
    Clin Exp Immunol; 1994 Sep; 97(3):353-60. PubMed ID: 7521806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.
    Rowland-Jones SL; Nixon DF; Aldhous MC; Gotch F; Ariyoshi K; Hallam N; Kroll JS; Froebel K; McMichael A
    Lancet; 1993 Apr; 341(8849):860-1. PubMed ID: 8096564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The presence of protective cytotoxic T lymphocytes does not correlate with shorter lifespans of productively infected cells in HIV-1 infection.
    Spits HB; Mudrikova T; Schellens IM; Wensing AM; Prins JM; Feuth T; Spierings E; Nijhuis M; van Baarle D; Borghans JA
    AIDS; 2016 Jan; 30(1):9-17. PubMed ID: 26731751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.
    Etschel JK; Hückelhoven AG; Hofmann C; Zitzelsberger K; Maurer K; Bergmann S; Mueller-Schmucker SM; Wittmann J; Spriewald BM; Dörrie J; Schaft N; Harrer T
    J Immunol Methods; 2012 Jun; 380(1-2):40-55. PubMed ID: 22510580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
    Kalams SA; Johnson RP; Dynan MJ; Hartman KE; Harrer T; Harrer E; Trocha AK; Blattner WA; Buchbinder SP; Walker BD
    J Exp Med; 1996 Apr; 183(4):1669-79. PubMed ID: 8666925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load.
    Sindhu ST; Ahmad R; Morisset R; Ahmad A; Menezes J
    J Virol; 2003 Feb; 77(3):1848-55. PubMed ID: 12525619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
    Betts MR; Krowka JF; Kepler TB; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger JA
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1219-28. PubMed ID: 10480635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
    Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization.
    Kundu SK; Dupuis M; Sette A; Celis E; Dorner F; Eibl M; Merigan TC
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1669-78. PubMed ID: 9870321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS.
    Wasik TJ; Wierzbicki A; Whiteman VE; Trinchieri G; Lischner HW; Kozbor D
    Eur J Immunol; 2000 Jan; 30(1):117-27. PubMed ID: 10602033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.